Tissue consequence of renin-angiotensin system activation;Conséquences tissulaires de l'activation du système rénine-angiotensine

Bulletin de l'Academie Nationale de Medecine

Volumn 188, Issue 4, 2004, Pages 611-620

  Michel, Jean Baptiste ^a   Dreux, M Claude ^b   Adolphe, Mme Monique ^b   Sraer, M Jean Daniel ^b   Vacheron, M André ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

Angiotensin; Angiotensin II. Receptor; Type I. Leukocytes. Aneurysm

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; PEPTIDE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENZYME INDUCTION; HYPERTENSION; HYPERTROPHY; LEUKOCYTE; NONHUMAN; PERIPHERAL CIRCULATION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 7444236385     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33751-3     Document Type: Review

References (35)

1. GOLDBLATT H. - The renal origin of hypertension. - Physiol. Rev., 1947, 27, 120-165.
2. VAN KESTEREN C.A., DANSER A.H., DERCKX F.H., et al. - Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension, 1997, 30, 1389-1396.
3. DE LANNOY L.M., DANSER A.H., VAN KATS J.P., et al. - Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension, 1997, 29, 1240-1251.
4. NGUYEN G., DELARUE F., BURCKLE C., et al. - Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest., 2002, 109, 1417-1427.
5. COULET F., GONZALEZ W., BOIXEL C., et al. - Endothelium-independent conversion of angiotensin I by vascular smooth muscle cells. Cell Tissue Res., 2001, 303, 227-234.
6. LEVY B.I. - Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease ? Implications for therapeutic blockade of the renin-angiotensin system. Circulation, 2004, 109, 8-13.
7. PUEYO M.E., N'DIAYE N., MICHEL J.B. - Angiotensin II-elicited signal transduction via ATI receptors in endothelial cells. Br. J. Pharmacol., 1996, 118, 79-84.
8. BERK B.C., CORSON M.A. - Angiotensin II signal transduction in vascular smooth muscle : Role of tyrosine kinases. Circ. Res., 1997, 80, 607-616.
9. WEIGERT C., BRODBECK K., KLOPFER K., et al. - Angiotensin II induces human TGF-beta 1 promoter activation : Similarity to hyperglycaemia. Diabetologia, 2002, 45 : 890-898.
10. GRIENDLING K.K., USHIO-FUKAI M. - Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept., 2000, 91, 21-27.
11. PAGANO P.J., CHANOCK S.J., SIWIK D.A., et al. - Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension, 1998, 32, 331-337.
12. KRANZHOFER R., SCHMIDT J., PFEIFFER C.A., et al. - Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1623-1629.
13. BROWN N.J., VAUGHAN D.E. - Prothrombotic effects of angiotensin. Adv. Intern. Med., 2000, 45, 419-429.
14. PUEYO M.E., GONZALEZ W., NICOLETTI A., et al. - Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 645-651.
15. BRILLA C.G., ZHOU G., MATSUBARA L., WEBER K.T. - Collagen metabolism in cultured adult rat cardiac fibroblasts : Response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol., 1994, 26, 809-820.
16. BROWN N.J., KUMAR S., PAINTER C.A., VAUGHAN D.E. - ACE inhibition versus angiotensin type 1 receptor antagonism : Differential effects on PAI-1 over time. Hypertension, 2002, 40, 859-865.
17. HENRION D., DOWELL F.J., LEVY B.I., MICHEL J.B.. - In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension, 1996, 28, 361-366.
18. PAGANO P.J., CLARK J.K., CIFUENTES-PAGANO M.E., et al. - Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia : Enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA, 1997, 94, 14483-14488.
19. LEWIS E.J., HUNSICKER L.G., CLARKE W.R., et al. - Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl J. Med., 2001, 345, 851-860.
20. PARVING H.H., LEHNERT H., BROCHNER-MORTENSEN J., et al. - The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med., 2001, 345 : 870-878.
21. MARRE M., JEUNEMAITRE X., GALLOIS Y., et al. - Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes : genetique de la nephropathie diabetique (GENEDIAB) study group. J. Clin. Invest., 1997, 99, 1585-1595.
22. PUEYO M.E., CHALLAH M., GAUGIER D., et al. - TGF-b1 production is correlated with genetically determined angiotensin-converting enzyme expression in congenic rats. Diabetes, 2004 (sous presse).
23. YAMADA H., FABRIS B., ALLEN A.M., et al. - Localization of angiotensin converting enzyme in rat heart. Circ. Res,. 1991, 68, 141-149.
24. BRIEN K.D., SHAVELLE D.M., CAULFIELD M.T., et al. - Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation, 2002, 106, 2224-2230.
25. JOHNSTON C.I., MOOSER V., SUN Y., FABRIS B. - Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin. Exp. Pharmacol. Physiol., 1991, 15, 107-110.
26. GAERTNER R., PRUNIER F., PHILIPPE M., et al. - Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 2002, 283, H156-164.
27. SUN Y., ZHANG J.Q., ZHANG J., RAMIRES F.J. - Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J. Mol. Cell. Cardiol., 1998, 30, 1559-1569.
28. CHALLAH M., VILLARD E., PHILIPPE M., et al. - Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. Arterioscler. Thromb. Vasc. Biol., 1998, 18, 235-243.
29. AMANT C., BAUTERS C., BODART J.C., et al. - D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation, 1997, 96, 56-60.
30. PARAGH G., SZABO J., KOVACS E., et al. - Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolaemia. Cell. Signal., 2002, 14, 787-792.
31. DAUGHERTY A., MANNING M.W., CASSIS L.A. - Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipo protein E-deficient mice. J. Clin. Invest., 2000, 105, 1605-1612.
32. WANG Y.X., MARTIN-McNULTY B., FREAY A.D., et al. - Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am. J. Pathol., 2001, 159, 1455-1464.
33. MANNING M.W., CASSI L.A., HUANG J., et al. - Abdominal aortic aneurysms : Fresh insights from a novel animal model of the disease. Vasc. Med., 2002, 7, 45-54.
34. DOL F., MARTIN G., STAELS B., et al. - Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J. Cardiovasc. Pharmacol., 2001, 38 : 395-405.
35. MENARD J., CAMPBELL D.J., AZIZI M., GONZALES M.F.. - Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation, 1997, 96, 3072-3078.